Abstract Introduction: Deep vein thrombosis (DVT) after varicose vein surgery is well recognised. Less well documented is endovenous heat-induced thrombosis (EHIT), thrombus extension into a deep vein after superficial venous thermoablation. We examined the rates of DVT in our unit after radiofrequency (RFA) and endovenous laser ablation (EVLA) with specific attention to thrombus type. Method: Retrospective analysis of all cases of RFA under general anaesthesia and EVLA under local anaesthesia was performed. Cases of DVT were identified from the unit database and analysed for procedural details. Results: In total, 2470 cases of RFA and 350 of EVLA were performed. Post-RFA, DVT was identified in 17 limbs (0.7%); 4 were EHIT (0.2%). Concomitant small saphenous vein (SSV) ligation and stripping was a risk factor for calf-DVT (OR 3.4, 95%CI 1.2e9.7, P Z 0.036), possibly due to an older patient group with more severe disease. Post-EVLA, 4 DVTs were identified (1%), of which 3 were EHIT (0.9%). Conclusion: The DVT rate including EHIT was similar in patients treated with RFA and EVLA and was low. Routine post-operative duplex ultrasound scanning is recommended until the significance of EHIT is better understood, in accordance with consensus guidelines. DVT rates for both techniques compare favourably with those published for saphenous vein stripping. ª
Introduction
Deep vein thrombosis (DVT) after varicose vein surgery is well recognised. 1, 2 With the growing popularity of endovenous thermo-ablative techniques, there have been numerous reports of the complication Endovenous HeatInduced Thrombosis (HIT). 3, 4 EHIT is thrombus extending from the superficial venous system into the deep venous system at, or proximal to, a site of recent thermoablation, most commonly thrombus extending from the great saphenous vein (GSV) into the common femoral vein (CFV, Fig. 1 ). 5 The aim of this study was to compare rates of venous thromboembolism (VTE) after endovenous radiofrequency (RFA) and laser ablation (EVLA) with specific attention to thrombus type and risk factors.
Method
A retrospective analysis of all cases of RFA and EVLA performed in the unit from February 1999 to March 2007 was conducted. Cases of DVT were identified from the unit database in which patient demographics, severity of venous insufficiency according to CEAP clinical classification, 6 procedural details and all complications are prospectively recorded. For those patients in whom post-operative DVT was identified, case notes were examined for previous venous thromboembolism (VTE), VTE risk factors, history of varicose vein surgery and procedural details. Redo procedures were classified as surgery to the same vein if any previous intervention had been performed (e.g. ligation or stripping procedure).
Radiofrequency ablation
Our technique for RFA has previously been described. 7 Briefly, all cases in this study were performed under general anaesthesia (GA) using the Closure Ò system (VNUS medical technologies, San Jose, California). Tumescent local anaesthesia was not used. High resolution scanners (Acuson Cypressä, Siemens, Issaquah, USA) handled by experienced vascular technologists were used for all procedures. A linear 7 MHz probe (Acuson Cypressä) was inserted in a sterile cover with acoustic coupling gel and using ultrasound guidance the GSV was cannulated percutaneously just below the knee. A 0.025-inch guide-wire was then inserted proximally to the CFV using the Seldinger technique. An RFA catheter, 6F or 8F according to the diameter of the GSV, connected to a pressurised heparinised saline infusion (5000 U in 500 ml of saline solution, 150 mmHg) was introduced as far as the saphenofemoral junction (SFJ). The leg was then bound with an Esmarch bandage to ensure good contact between the vein wall and catheter electrodes by venous exsanguination. After confirming the proximal limit of the catheter to be within 2 cm of the SFJ, radiofrequency energy delivery was commenced with a temperature of 85 C. An initial "ring burn" was delivered for 15 s, and the catheter was then withdrawn a distance of 1 cm in the first minute, 2 cm in the second minute, and 2.5e3 cm/ min thereafter, depending on the diameter of the vein. Postprocedure, the vein was checked immediately with duplex ultrasound (DUS) for closure. Any incompetent tributaries of the GSV were treated concomitantly, as were incompetent perforator veins (IPV), either with DUS-guided perforator ligation or TransLuminal Occlusion of Perforator (TRLOP) with RFA. 8 Adjunctive phlebectomies were also performed to remove superficial varicosities which had been marked preoperatively on the skin. Incompetent small saphenous veins (SSV) were treated with concomitant DUS-guided saphenopopliteal ligation and strip as previously described. 9 After the procedure a crêpe bandage was applied firmly to the leg and thigh over Velband Ò (Johnson & Johnson Medical, Ascot, Berkshire). This was replaced the next day with a graduated compression stocking.
Endovenous laser ablation
EVLA was introduced as a treatment option to patients in the unit in May 2005, and all cases performed to March 2007 were included. All cases of EVLA were performed under tumescent local anaesthesia as walk-in, walk-out procedures. The GSV was cannulated percutaneously just below the knee under ultrasound guidance using the Seldinger technique. The laser sheath was advanced to the SFJ and the guide-wire removed. Tumescent anaesthesia was infiltrated in the perivenous space under ultrasound guidance (Acuson Cypressä) using an AutoFill Ò syringe (Vascular Solutions Inc., Minneapolis, USA). 0.5 l of tumescent local anaesthesia was prepared using 500 ml 0.9% saline, 20 ml of 2% xylocaine and adrenaline and 5 ml of 8.4% sodium bicarbonate according to Klein's formula. 10 The laser fibre was inserted to a position within 2 cm of the SFJ with ultrasound guidance and connected to an 810 nm diode laser (Vari-Lase Ò , Vascular Solutions Inc., Minneapolis, USA). Laser energy was then administered at 14 W power using a continuous setting, aiming for a linear energy delivery target of 70 J/cm. Refluxing tributaries were treated with EVLA concomitantly. Treatment of superficial varicosities and IPV was performed at a later date.
Pre-operative evaluation and post-operative follow-up All patients were diagnosed pre-operatively with superficial venous insufficiency according to DUS (SONOLINE Antares, Figure 1 Appearance of Endovenous Heat-induced thrombosis (EHIT) extending from the great saphenous vein (GSV) into the common femoral vein (CFV) on duplex ultrasound scan.
Siemens, Issaquah, USA) using a standard protocol and treatment was guided by DUS-directed vein mapping. Vein incompetence was assessed with reflux in response to manual calf compression or Valsalva manoeuvre with the patient standing and reflux was defined as evidence of reverse flow >500 ms in a vein segment. 11 Any patients undergoing endovenous thermoablation procedures routinely received one dose of low molecular weight (LMW) heparin prophylaxis (4000 i.u. enoxaparin sodium, Sanofiaventis, Guildford, UK), unless warfarinised for co-morbid conditions (immediately post-operatively for EVLA, intraoperatively for RFA). All patients were given 20e30 mm Hg graduated compression stockings (Venosan Ò , Saltzman, Switzerland) to wear 24 h a day for at least 3 days. Routine mobilisation was encouraged for the post-operative period. A duplex ultrasound examination was performed within the first two post-operative weeks, to assess the treated vein segment and exclude DVT, with special attention paid to the SFJ and calf muscle veins. EHIT was classified as previously described. The presence of thrombus in gastrocnemius, posterior tibial or popliteal veins was classified as calf-DVT.
Statistical analysis
Statistical analysis was performed using Interstat 3 and Prism software (GraphPad Software, Inc., San Diego, California, USA). Intergroup comparisons were made with the Student t or ManneWhitney u test as appropriate for normally and nonnormally distributed data, respectively (TT). Univariate analysis was performed to estimate the effect of selected risk factors using the chi-squared test for contingency tables. A P value <0.05 was considered statistically significant.
Results

Patient characteristics
RFA was performed on 2470 limbs and EVLA on 350 limbs during the period examined. Patient demographics are summarised (Table 1) . Basic patient characteristics were similar with the exception of the higher median age in the EVLA group.
Post-operative DVT and EHIT
Post-RFA, DVT was identified in 17 limbs (0.7%). Of these, 4 were EHIT and 14 were calf-DVT. In one patient, both types of thromboses were present, along with pulmonary embolism (PE). This was the only case of PE (confirmed on CT pulmonary angiography) in the series (0.04%). The patient presented at routine follow-up 8 days post-RFA complaining of foot drop since the procedure and chest pain for 36-h. Nerve conduction studies demonstrated no abnormality and the patient made a full recovery. Post-EVLA, 4 DVTs were identified (1%): of these, 3 were EHIT and one a calf-DVT, all post-GSV ablation. The calf-DVT presented after the patient underwent subsequent treatment of an IPV. Length of GSV treated and energy applied in each case are described (Table 3) . Of the limbs treated with EVLA, 48 cases were small saphenous veins. There was no DVT or EHIT in this sub-group. The frequency of EHIT was similar following RFA and EVLA but since this event occurred in very few patients no reliable statistical analysis is possible (Table 2) .
Risk factors for DVT and EHIT
There was no significant difference between the age of the patients who had a calf-DVT or EHIT post-RFA or EVLA and the population undergoing RFA as a whole, nor was there a difference in the proportions of limbs in each clinical score. Of the patients with calf-DVT post-RFA, 3 had previous DVT (21%). None of the patients with EHIT post-RFA had a history of DVT, in contrast with 2 of 3 patients with the condition post-EVLA, one of whom had evidence of this on pre-operative DUS. Other possible risk factors were present for 2 of the calf-DVT post-RFA (no cessation of oral contraceptive pill, hormone replacement therapy use), though for none of the EHIT in the series. All patients with calf-DVT or EHIT had received heparin prophylaxis (Table 4) .
Post-RFA, the rate of calf-DVT for bilateral surgery compared with unilateral surgery was similar (P Z N.S.). Redo surgery compared with primary surgery did not cause a higher rate of DVT. Concomitant small saphenous surgery (SST) with RFA was found to be a risk factor for calf-DVT when compared with RFA and no small saphenous surgery (P Z 0.036). No significant difference was seen between the rate of calf-DVT for concomitant RFA and SST procedures, and small saphenous surgery procedures performed in the same period alone (P Z N.S.) suggesting concomitant small saphenous surgery itself to be a possible risk factor for calf-DVT post-RFA. Further analysis demonstrated that patients in the RFA and concomitant SST group were significantly older, with limbs in a higher CEAP clinical class than patients who had RFA without SST (P Z 0.028 and P 0.0001). When comparing those groups having any small saphenous surgery (RFA þ SST or SST alone), patients were similar for age and CEAP clinical class.
The significance of treatment of IPVs with the TRLOP method was also examined. An increased OR of calf-DVT was seen after RFA and TRLOP compared with RFA and no TRLOP 
RFA, radiofrequency ablation, EVLA, endovenous laser ablation, SD, standard deviation.
(OR 5.8, P Z 0.02). No significant difference in the rate of calf-DVT after RFA and TRLOP was seen compared with TRLOP alone performed without RFA of a truncal vein in the same period (OR 3.4, P Z 0.28). It was noted that 6 of the calf-DVT seen after TRLOP were also associated with small saphenous surgery, and so these were analysed separately. There was no increased risk of calf-DVT after RFA and TRLOP and no small saphenous surgery compared with RFA alone (also excluding those with small saphenous surgery). However, the odds ratio of calf-DVT after RFA and TRLOP with small saphenous surgery was significantly elevated when compared with RFA and TRLOP and no small saphenous surgery (OR 3.5, P Z 0.03). Of the calf-DVT seen with concomitant small saphenous surgery, all patients also had concomitant treatment of an IPV in the same limb (n Z 7). Although 6 of these had the TRLOP procedure, 1 patient had duplex-guided perforator ligation. The OR of calf-DVT with RFA and small saphenous surgery and treatment of an IPV was significantly elevated compared with those who did not have IPV treatment (OR 14.7, P Z 0.015, Table 5 ).
Management of DVT/EHIT
The management of patients with EHIT evolved in the series (Table 6 ). The first patient with EHIT post-RFA was managed with open saphenofemoral thrombectomy, SFJ ligation and anticoagulation with warfarin for 6 weeks. Subsequently, the patients with isolated EHIT post-RFA were treated medically with warfarin for a one-month period (3-months for the patient with PE). Similarly for patients with EHIT post-EVLA: one patient was warfarinised for a 1-month period, one patient was treated with a therapeutic once e daily dose of low molecular weight heparin and one patient was observed without treatment, without consequence. Regression of thrombus from the deep vein was established on DUS before cessation of anticoagulation in all patients. With the exception of the patient with calf-DVT thought to be related to IPV treatment post-EVLA (in whom the DVT resolved without treatment after 5 days), all patients with isolated calf-DVT post-RFA and EVLA were warfarinised (mean 10 weeks, range 3e14 weeks). No caval filters were utilised.
Discussion
We found a low incidence of DVT after EVLA and RFA in this retrospective analysis with no clear difference between these treatments and very few EHITs were seen. The mechanism of EHIT formation is not fully understood. Superficial venous thrombus is expected following thermoablation, whether this is by thrombotic vessel occlusion or local vessel injury from direct thermal damage or steam bubbles. 12, 13 Thrombus may form in the deep veins or propagate from treated superficial veins to the deep veins.
Reported rates of DVT post-endovenous ablation techniques vary widely from 0 to 16% post-RFA and 0 to 7.7% post-EVLA. 4 Rates after conventional surgery vary between 0.4% historically and 5.7% with prospective ultrasound.
1,2
The series reported here includes our learning curve for EVLA but despite this we did not observe a difference in DVT rates between EVLA and RFA.
Factors which may increase the risk of EHIT include: patient age, undiagnosed hypercoagulable states and severity of chronic venous disease. 14, 15 Factors related to the procedure include: the use of GA, maintenance of patency of superficial venous tributaries at the most proximal point of thermoablation, avoidance of catheterising the CFV to avoid intimal damage and the avoidance of propagation of steam bubbles (or thrombus) by compression or ligation of the SFJ, though a recent survey has indicated no difference in DVT rate of ligators and non-ligators.
3,16e18 Our practice was to perform RFA under GA using an Esmarch bandage to exsanguinate the limb. We did not use tumescent anaesthesia in this group in order to avoid the "heat sink" effect, without adversely affecting the DVT rate. Additionally, it has been our practice to perform concomitant phlebectomy in these patients. In the first 127 cases of RFA performed in this series, we found that 57% of superficial epigastric veins (SEV) remained patent with no relationship with neovascularisation at the SFJ or GSV recanalisation, a finding also seen post-EVLA. 7, 19 Nevertheless, it has not been our practice to routinely commence ablation below this vein in part due to the variability of its site. We commenced thermoablation within 2 cm of the SFJ, regardless of SEV site and routinely used a guide-wire, placing the catheter in the CFV and withdrawing the tip into the saphenofemoral hood.
The small numbers of EHIT seen prevented meaningful analysis of risk factors but larger numbers of calf-DVT post-RFA enabled further analysis of this sub-group. Surprisingly the rate of calf-DVT was reduced in patients having bilateral surgery compared with unilateral, contrary to expectation and findings of others. 20 The significantly increased rate of calf-DVT seen in patients undergoing concomitant small saphenous surgery and RFA is possibly attributable to the increased age and clinical severity score in this group of patients, as their risk of calf-DVT was found to be similar to those undergoing small saphenous surgery alone. No DVT was seen following EVLA of small saphenous veins, although there were few of these cases.
Initially TRLOP appeared to be an isolated risk factor for calf-DVT but this was linked to concomitant small 
DVT, deep vein thrombosis, EHIT, endovenous heat-induced thrombosis, PE, pulmonary embolism, RFA, radiofrequency ablation, EVLA, endovenous laser ablation, RF, risk factor, SST, small saphenous surgery, TRLOP, transluminal occlusion of perforator, AAGSV, anterior accessory great saphenous vein. saphenous surgery, with no increased risk of calf-DVT for RFA with TRLOP in its absence. Any treatment of IPV with concomitant small saphenous surgery was associated with elevated risk of DVT. Whether this is a result of the small saphenous surgical procedure itself or due to the increased age and more severe disease of these patients is unknown. The number of IPVs present has been correlated with clinical severity and development of new IPV with worsening of chronic venous disease. 21, 22 Varicose vein patients with more advanced disease appear to have a higher risk of DVT.
All patients with DVT or EHIT in this series received a single dose of prophylactic LMW heparin. Failure of this strategy for prophylaxis has been reported previously, especially in patients with a history of VTE. 1, 23 This suggests that a greater duration of prophylaxis may be appropriate in patients with a history of VTE, as has been suggested previously. 24 Pre-operative anticoagulation might interfere with thrombotic vessel occlusion. 25 A low DVT rate in a large series (0.1%) was attributed to post-operative treatment with non-steroidal anti-inflammatory drugs for their anti-platelet activity and analgesic effect. 17 Class II graduated compression stockings may also be useful.
EHIT management has evolved in published reports from operative thrombectomy, and later anticoagulation was introduced with or without saphenofemoral ligation. 3, 26 Caval filters and thrombolysis have also been used, though most authors now agree that treatment with low molecular weight heparin is adequate for most cases. 14, 15, 27 In this series, of the patients with EHIT post-EVLA, 2 were anticoagulated and one was observed. The latter patient had a knuckle of thrombus protruding 1 cm into the femoral vein that was later seen to have resolved with no adverse sequelae. Notwithstanding, we would agree that such patients are probably most safely managed with LMW heparin until resolution on ultrasound in accordance with the suggested treatment algorithm Kabnick introduced with his classification system ( Table 7) . 5 All cases of EHIT in this series were Kabnick class 2e4.
The risk of pulmonary embolism from EHIT remains undefined and is uncommon after open varicose vein surgery. 28 We are unaware of any reports of patients with PE directly in association with isolated EHIT, although there is a report where it is not clear if calf-DVT has been excluded. 27 The patient in this study with PE had thrombus present in gastrocnemius veins as well as at the SFJ, similar to a previously described case. 3 Routine post-operative DUS should be performed specifically to seek the presence of EHIT in accordance with consensus guidelines and therapeutic management instigated and continued until absence of CFV thrombus. The DVT rate including EHIT was similar in patients treated with RFA and EVLA and was low. Calf-DVT occurred in patients with a history of thromboembolism and in those being treated for more complex venous disease. DVT rates for both endothermal ablation techniques compare favourably with those published for saphenous vein stripping.
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